Cyclacel Pharmaceuticals, Inc(NASDAQ:CYCC) 
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial f...
Website: http://www.cyclacel.com
Founded: 1996
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-03-14
P
O 69.57
H 71.96
L 69.57
C 71.96
V 92,539
10EMA 71.96
20EMA 71.96
60EMA 71.96
120EMA 71.96
250EMA 71.96